Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services is a UK-based contract manufacturing organisation specializing in GMP manufacture and sterile fill/finish of vials for clinical trials and low-volume commercial supply. With a focus on regulatory compliance, technical capability, and operational flexibility, Symbiosis operates from a purpose-built MHRA-licensed and FDA approved facility, enabling it to handle products requiring aseptic liquid filling and lyophilisation, including biologics, viral vectors for gene therapies, and small molecule drugs.

One of the company's key strengths is fast access to manufacturing slots and accelerated release of drug product, allowing it to meet demand for small-scale, fast-turnaround drug product manufacturing while ensuring compliance with the highest standards. Symbiosis specializes in the sterile fill/finish of biologic and small molecule products into vials, including liquid or lyophilised formulations, and has the capabilities to handle and fill antibodies, proteins, peptides, nucleic acids, cytotoxic, cytostatic, highly potent APIs, and conventional small molecules.

Founded in 2011, the company operates in the biopharma, biotechnology, and manufacturing industries. Its slogan, "Aseptic Manufacturing Specialists - Leading the Way in Viral Vectors," reflects its commitment to service excellence through flexibility, responsiveness, and timeliness, ultimately aiming to save clients invaluable development time and facilitate a quick entry into phase I/II clinical trials.